Product Images Tizanidine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Tizanidine Hydrochloride NDC 42549-597 by Stat Rx Usa Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANELTizanidine 2mg, 28 tablets - Tizanidine 2 mg Label 42549
The text seems to describe a packaged medication containing 2.288mg of Tizanidine. The manufacturer is Sandoz and the product has a National Drug Code (NDC) of 42549-549-30. The medication is distributed in tablets and contains 1 to 2mg of the active ingredient. The medication's lot number is 27384 and it should be discarded by May 15th, 2012. The rest of the text appears to be garbled and not usable.*
PRINCIPAL DISPLAY PANELTizanidine 4mg, 28 tablets - Tizanidine 4 mg Label 42549
This appears to be a description of a medication containing tizanidine in tablet form. The medication is packaged and distributed by BSTAT in Gainesville, USA. Each tablet contains 4.576mg of tizanidine, which is equivalent to 4mg of tizanidine base. It has a lot number of GRXISO0 and an expiration date of 03/13 by 11/29/2011. The medication may cause drowsiness, and consuming alcohol while taking it is not recommended. However, it is unclear what the text meant by "Vesu abexoed o" since it is not a readable text in any known language.*
Chemical Structure - Tizanidine Chem Structure
Figure 1 - tizanidine 2
The text describes a graph showing plasma Tizanidine concentration level in milligrams per milliliter over time. The x-axis represents the time in hours after dosing, and the y-axis represents the concentration level. The text also provides information on dosing, specifying that two 4 mg Tizanidine tablets can be taken with or without food.*
Figure 2 - tizanidine 3
The text describes a graph showing the Improvement in Ashworth Score after taking either 16 mg or 8 mg tizanidine or placebo at different hours post-dose. No other information is available.*
Figure 3 - tizanidine 4
The text describes the improvement in Ashworth Score for Tizanidine versus a placebo during a clinical trial with a mean dose of 28.8 mg. It specifies the observation points: end of titration, end of maintenance, and endpoint.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.